| Date Filed | Type | Description |
| 10/03/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 25,000 shares
@ $12.41, valued at
$310.3k
|
|
| 09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 15,000 shares
@ $10.14, valued at
$152.1k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $6.3, valued at
$63k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $6.045, valued at
$30.2k
Sold 5,000 shares
@ $6.295, valued at
$31.5k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| Harmon Cyrus (CHIEF TECHNOLOGY OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 400 shares
@ $24.76, valued at
$9.9k
|
|
| 10/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Harmon Cyrus (Chief Technology Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 71,374 shares
@ $0
Converted 122,028 shares
@ $0
Converted 71,374 convertible preferred
@ $0
Converted 122,028 convertible preferred
@ $0 |
|
| 11/20/2020 |
4/A
| Harmon Cyrus (Chief Technology Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 1,076 options to buy
@ $19, valued at
$20.4k
|
|
| 11/19/2020 |
4
| Harmon Cyrus (Chief Technology Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 143,472 shares
@ $0
Granted 227,859 options to buy
@ $4.824, valued at
$1.1M
Granted 179,340 options to buy
@ $19, valued at
$3.4M
|
|
| 11/18/2020 |
3
| Harmon Cyrus (Chief Technology Officer) has filed a Form 3 on Olema Pharmaceuticals, Inc. |